跳至主要内容
临床试验/NCT04725396
NCT04725396已完成不适用

A Randomized Prospective Multicenter Study Comparing Fibula Free-flap Mandibular Reconstruction With or Without Preoperative Virtual Planning in Patients With Oral or Oropharyngeal Cancer

UNICANCER12 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2021年4月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
UNICANCER
入组人数
132
试验地点
12
主要终点
General Oral Health Assessment Index (GOHAI)

研究概览

简要总结

This is a national multicenter, randomized, stratified, open label study, aiming to compare mandibular reconstruction (MR) with or without preoperative virtual planning (PVP), in patients with oral/oropharyngeal cancer (OOPC).

详细描述

PVP-assisted MR includes the production of the surgical cutting guides required for mandibular resection and fibula free-flap conformation and of the preformed plates for flap osteosynthesis (for all patients, PVP will be done by the same laboratory: Materialise laboratory).

PVP-assisted MR includes the production of :

  • surgical cutting guides required for mandibular resection and fibula free-flap conformation
  • preformed plates for flap osteosynthesis

Patients will be selected after the multidisciplinary decision of oncological surgery including segmental mandibulectomy and immediate MR. Patients will be randomized in 2 groups (ratio 1:1, stratified on center and tumor N status [0-1 vs 2-3]).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 years or over
  • Primary or recurrent OOPC, histologically proven, requiring segmental mandibulectomy
  • Planned immediate fibula free flap MR to be performed at the same time as the tumor ablation by segmental mandibulectomy
  • MR requiring at least one osteotomy for contouring the flap (i.e. at least 2 bone fragments)
  • East Cooperative Oncology Group (ECOG) performance status 0 or 1
  • American Society of Anesthesiologists Physical Status (ASA) score 1, 2, or 3
  • Patients considered fit for surgery as decided by the multidisciplinary team
  • Patients must be willing and able to comply with the protocol for the duration of the study including scheduled visits, treatment plan, laboratory tests and other study procedures
  • Patients must be affiliated to a Social Security System (or equivalent)
  • Patients must have signed a written informed consent form prior to any trial specific procedures. If the patients are physically unable to give their written consent, a trusted person of their choice, not related to the investigator or the sponsor, can confirm in writing the patient's consent

排除标准

  • Non resectable tumors (T4b primary tumor, non resectable metastatic lymph nodes)
  • Comorbidities factors that would contraindicate surgery (such as severe peripheral artery disease)
  • MR requiring no osteotomy for contouring the flap (i.e. one bone fragment)
  • Patients with distant metastatic disease as determined by routine pre-operative staging radiological investigations e.g. CT thorax and upper abdomen or positron emission tomography (PET)-CT
  • Other uncontrolled malignancy
  • Serious, non-healing or dehiscing wound, active ulcer or ongoing bone fracture at the free-flap donor site
  • Patients unwilling or unable to comply with the medical follow-up required by the trial because of psychosocial, familial, social, or geographical reasons
  • Participation in another clinical study with an investigational medicinal product during the last 30 days prior to inclusion
  • Patients deprived of their liberty or under protective custody or guardianship

结局指标

主要结局

General Oral Health Assessment Index (GOHAI)

时间窗: 1-year

Oral health-related quality of life (QoL) measured 1 year after surgery using the GOHAI in the 2 groups of patients (MR with or without PVP). The GOHAI is an oral-disease-specific QoL measure made by the patient. The GOHAI comprises 12 items grouped into three dimensions: the functional dimension (eating, speaking, swallowing); the pain or discomfort dimension (drugs, gingival sensitivity, discomfort when chewing certain foods); and, the psychosocial dimension (concerns, relational discomfort, appearance). The response format for each item is based on a five-point Likert scale: always = 1; often = 2; sometimes = 3; seldom = 4; never = 5. A summary score (ranging from 0 to 60) is calculated for each patient with a higher score indicating better oral health. GOHAI scores close to 30 have been reported in head and neck cancer patients after oncologic surgery and pedicled or free flap reconstruction.

次要结局

  • Total operative time and flap ischemia time(Post surgery, up to 45 days after randomization)
  • Postoperative surgical complication rate (including free-flap failure rate)(Post surgery, up to 45 days after randomization)
  • Delayed surgical complication rate(Post surgery, up to 45 days after randomization)
  • Pain in the head and neck area(At 1 year)
  • Time between randomization and surgery(At the time of surgery, up to 45 days after randomization)
  • Functional outcome: Performance Status Scales for Head and Neck (PSS-HN)(At baseline and at 1 year)
  • Functional outcome: Mouth opening range/capacity(At baseline and at 1 year)
  • Functional outcome: MD Anderson Dysphagia Inventory (MDADI)(1 year)
  • Functional outcome: Speech Handicap Index (SHI)(1 year)
  • Functional dental status(At baseline and at 1 year)
  • Aesthetic outcome(1 year)
  • Morphological results: mandibular angle(At 1 year)
  • Morphological results: bi-gonial diameter(At 1 year)
  • Morphological results: position of the gnathion(At 1 year)
  • Evolution of patient QoL: GOHAI score(At baseline, at 6 months, and at 1 year)
  • Evolution of patient QoL: Quality of life questionnaire - Core 30 (QLQ-C30) score(At baseline, at 6 months and at 1 year.)
  • Evolution of patient QoL: Quality of Life Questionnaire - Head & Neck Cancer Module (QLQ-H&N35) score(At baseline, at 6 months and at 1 year.)
  • Time between randomization and surgery(At the time of surgery, up to 45 days after randomization)
  • Total operative time and flap ischemia time(Post surgery, up to 45 days after randomization)
  • Postoperative surgical complication rate (including free-flap failure rate)(Post surgery, up to 45 days after randomization)
  • Delayed surgical complication rate(Post surgery, up to 45 days after randomization)
  • Functional outcome: Performance Status Scales for Head and Neck (PSS-HN)(At baseline and at 1 year)
  • Functional outcome: Mouth opening range/capacity(At baseline and at 1 year)
  • Functional outcome: MD Anderson Dysphagia Inventory (MDADI)(1 year)
  • Functional outcome: Speech Handicap Index (SHI)(1 year)
  • Functional dental status(At baseline and at 1 year)
  • Aesthetic outcome(1 year)
  • Morphological results: mandibular angle(At 1 year)
  • Morphological results: bi-gonial diameter(At 1 year)
  • Evolution of patient QoL: Quality of Life Questionnaire - Head & Neck Cancer Module (QLQ-H&N35) score(At baseline, at 6 months and at 1 year.)
  • Morphological results: position of the gnathion(At 1 year)
  • Pain in the head and neck area(At 1 year)
  • Evolution of patient QoL: GOHAI score(At baseline, at 6 months, and at 1 year)
  • Evolution of patient QoL: Quality of life questionnaire - Core 30 (QLQ-C30) score(At baseline, at 6 months and at 1 year.)

研究者

发起方
UNICANCER
申办方类型
Other
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验